This indicated that the expression of TREM-2 significantly increased in lung cancer patients compared to that of the healthy controls, and that in pulmonary MΦs had a positive correlation with pathological TNM staging of lung cancer. This evidence concerns the gene TREM2 and lung carcinoma.